News
Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...
Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.
Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...
Abbott (NYSE: ABT) shares dipped before hours today on second-quarter results that came in ahead of the consensus forecast.
The Motley Fool. DATE Thursday, July 17, 2025 at 9 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — Robert ...
Q2 2025 Results Conference Call July 17, 2025 9:00 AM ETCompany ParticipantsMichael Comilla - Vice President of ...
Abbott Laboratories(NYSE:ABT) reported its second-quarter 2025 results on July 17, 2025, posting 7.5% organic sales growth (excluding COVID testing), 12% medical device growth, and adjusted EPS of $1.
Wall Street futures are trading little changed at this hour in the premarket session on Thursday (July 17). Dow Jones futures ...
Abbott, a global healthcare leader, has reported strong results for its second quarter of 2025. According to the company's ...
General Motors' Hummer EV and Ford's F-150 Lightning beat Tesla's Cybertruck in the US electric pick-up market for Q2 2025.
Elon Musk's dream of having a top-selling electric pickup may be a thing of the past as the Cybertruck continues to see ...
President Trump on Wednesday said he would be sending letters to over 150 countries as he plans a barrage of duties to take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results